BML Investment Partners, L.P. - 07 May 2025 SCHEDULE 13D Report for AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share (ANTX)

Filing Manager: BML Investment Partners, L.P.
Reporting Manager: BML Investment Partners, L.P.
Security: AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share
Symbol: ANTX
Shares outstanding: 30,101,738 shares
Disclosed Ownership: 5,749,432 shares
Ownership: 19.1%
Form type: SCHEDULE 13D
Filing time: 07 May 2025, 10:27:57 UTC
Date of event: 07 May 2025
Previous filing: 13 Feb 2025
Next filing: 30 May 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BML Investment Partners, L.P.	19.1%	5,749,432	0	5,749,432	Braden M Leonard	Braden M Leonard - Managing Member of BML Capital Management, LLC	0001373604